Achieve Life Sciences Inc (ACHV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,395 | -13,201 | -9,528 | -5,904 | -12,687 |
| Depreciation Amortization | 254 | 192 | 130 | 65 | 282 |
| Accounts payable and accrued liabilities | 715 | 430 | 563 | 550 | -69 |
| Other Working Capital | -273 | 290 | 61 | 660 | 928 |
| Other Operating Activity | 483 | 487 | 44 | -260 | 923 |
| Operating Cash Flow | $-15,216 | $-11,802 | $-8,730 | $-4,889 | $-10,623 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 5,089 | 5,089 | 5,089 | 2,744 | -5,089 |
| PPE Investments | -53 | -52 | -52 | -54 | -36 |
| Investing Cash Flow | $5,036 | $5,037 | $5,037 | $2,690 | $-5,125 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4,199 | 4,622 | 4,622 | N/A | 18,478 |
| Other Financing Activity | 13,126 | 0 | 0 | 0 | 1,279 |
| Financing Cash Flow | $17,325 | $4,622 | $4,622 | $N/A | $19,757 |
| Exchange Rate Effect | 4 | 3 | 2 | 4 | N/A |
| Beginning Cash Position | 9,565 | 9,565 | 9,565 | 9,565 | 5,556 |
| End Cash Position | 16,714 | 7,425 | 10,496 | 7,370 | 9,565 |
| Net Cash Flow | $7,149 | $-2,140 | $931 | $-2,195 | $4,009 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,216 | -11,802 | -8,730 | -4,889 | -10,623 |
| Capital Expenditure | -53 | -52 | -52 | -54 | -46 |
| Free Cash Flow | -15,269 | -11,854 | -8,782 | -4,943 | -10,669 |